Serum 25-Hydroxy Vitamin D in Chronic Rhinosinusitis with and Without Nasal Polyposis: A Case-Control Study in Northern Iran

Document Type: Original


1 Otorhinolaryngology Research Center, Department of Otolaryngology and Head and Neck Surgery, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

2 International Campus, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.


Chronic rhinosinusitis (CRS) with and without nasal polyposis is a chronic inflammatory disease of the sinuses and nasal mucosa. Recent evidence has indicated a relationship between serum 25-hydroxyl vitamin D (OH-VitD) deficiency and CRS. Regarding this, the present study aimed to compare the serum level of 25-OH-VitD in CRS patients with and without nasal polyposis and control groups.
Materials and Methods:
This study was conducted on 117 adult subjects in three groups of CRS with nasal polyposis (CRSwNP; n=32), CRS without nasal polyposis (CRSsNP; n=35), and healthy controls (n=50). The mean level of serum 25-OH-VitD in the three groups was measured by means of enzyme- linked immunosorbent assay. The data were analyzed using SPSS software (version 18).
Mean serum levels of 25-OH-VitD in CRSwNP, CRSsNP, and control groups were 12.52, 15.54, and 22.04 ng/ml, respectively. There was a significant difference between the case and control groups in terms of 25-OH-VitD level (P=0.0001). However, no significant difference was observed between the CRSwNP and CRSsNP groups in this regard (P=0.464). The women had a VitD deficiency odds ratio (OR) of 2.47, compared with men (OR=2.47, 95% CI=1.04-5.86). The OR of VitD deficiency with aging was obtained as 0.957 (95% CI=0.925-0.989). In this regard, older patients had a lower probability of VitD deficiency, compared to younger patients.
As the findings indicated, serum 25-OH-VitD was significantly lower in CRS patients, compared with that in the non-CRS subjects.


Main Subjects

1. Desrosiers M, Evans GA, Keith PK, Wright ED, Kaplan A, Bouchard J, et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy, Asthma & Clinical Immunology 2011;7(1): 2-7.

2. Hamilos DL. Chronic rhinosinusitis: Epidemiology and medical Management. J Allergy Clin Immunol 2011;128(4):693-707.

3. Nemati SMojtahedi ANaghavi SBanan RZia F. Investigating Helicobacter pylori in nasal polyposis using polymerase chain reaction, urease test and culture. Eur Arch Otorhinolaryngol 2012; 269(5): 1457–61.

4. Kulie TE, Groff  AM, Redmer JA, Hounshell JE, Schrager S. Vitamin D: An Evidence-Based Review. Journal of the American Board of Family Medicine 2009; 22:698–706.

5. White JH. Vitamin D Signaling, Infectious Diseases, and Regulation of Innate Immunity. Infect. Immun 2008; 76(9): 3837–43.

6. Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Branscheidt M, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respiratory Research 2011; 12(1):31.

7. Castro M, King TS, Kunselman SJ, Cabana MD, Denlinger L, Holguin F, et al. Effect of Vitamin D3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels The VIDA Randomized Clinical Trial. JAMA 2014; 311(20):2083-91.

8. Murdoch DR, Slow S, Chambers ST, Jennings LC, Stewart AW, Priest PC, et al. Effect of Vitamin D3 Supplementation on Upper Respiratory Tract Infections in Healthy Adults The VIDARIS Randomized Controlled Trial. JAMA 2012; 308(13):1333-9.

9. Khoo AL, Chai L, Koenen H, Joosten I, Netea M, Ven VA. Translating the role of vitamin D3 in infectious diseases. Crit Rev Microbiol 2012; 38(2):122-35.

10. Kern RC, Liddy W. Pathogenesis of chronic rhinosinusitis. In Flint PW, Haughey BH, Lund VJ, et al (Eds).Cumming's otolaryngol. Head & neck surg. ELSEVIER, Philadelphia 2015:714-22.

11. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, et al. Vitamin D
deficiency and causative factor in the population of Tehran. BMC public Health 2004; 4(1):38.

12. Hovsepian S, Amini M, Aminorroaya A, Amini P, Iraj B. prevalence of vitamin D deficiency among adult population of Isfahan city, Iran. J Health Popul Nutr 2011;29(2):149.

13. Sherman SS, Hollis BW, Tobin JD. Vitamin D Status and Related Parameters in a Healthy Population: The Effects of Age, Sex, and Season. J Clin Endocrinol Metab 1990; 71(2):405-13.

14. Zadshir ATareen NPan DNorris KMartins D. the prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethnicity & Disease 2005; 15(4):97-101.

15. Bolland MJ, Grey AB, Ames RW, Horne AM, Mason BH, Wattie DJ, et al. Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clinical Endocrinology 2007; 67(2): 259-64.

16. Apuhan T, Buğdaycı G, Alcelik A, Aktas G. Serum Levels of Vitamin D Among Patients with Nasal Polyps in Bolu Turkey.J Aller Ther 2011;5:1-3.

17. Mulligan JKBleier BSO'Connell BMulligan RMWagner CSchlosser RJ. Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis. Clin Exp Immunol 2011; 164(3):312-20.

18. Bozkurt SI, Alkan BE ,Yildiz FA, et al. Age, Sex, and Seasonal Variations in the Serum Vitamin D3 Levels in a Local Turkish Population. Arch Rheumatol 2014;29(1):14-19.

19. Alagöl F, Shihadeh Y, Boztepe H, Tanakol R, Yarman S, Azizlerli H, et al. Sunlight exposure and vitamin D deficiency in Turkish women. J Endocrinol Invest 2000; 23(3): 173-77.

20. Guzel RKozanoglu EGuler-Uysal FSoyupak SSarpel T. Vitamin D Status and Bone Mineral Density of Veiled and Unveiled Turkish Women. Journal of Women's Health & Gender-Based Medicine 2001; 10(8): 765-70.